Chao Yu-Kai, Chang Sui-Yuan, Grimm Christian
Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany.
Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
Rev Physiol Biochem Pharmacol. 2023;185:259-276. doi: 10.1007/112_2020_31.
Among the infectious diseases caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, the most prevalent ones today are malaria, tuberculosis, influenza, HIV/AIDS, Ebola, dengue fever, and methicillin-resistant Staphylococcus aureus (MRSA) infection, and most recently Covid-19 (SARS-CoV2). Others with a rather devastating history and high fatality rates such as plague, cholera, or typhus seem less threatening today but have not been eradicated, and with a declining efficacy of current antibiotics they ought to be watched carefully. Another emerging issue in this context is health-care associated infection. About 100,000 hospitalized patients in the USA ( www.cdc.gov ) and 33,000 in Europe ( https://www.ecdc.europa.eu ) die each year as a direct consequence of an infection caused by bacteria resistant to antibiotics. Among viral infections, influenza is responsible for about 3-5 million cases of severe illness, and about 250,000 to 500,000 deaths annually ( www.who.int ). About 37 million people are currently living with HIV infection and about one million die from it each year. Coronaviruses such as MERS-CoV, SARS-CoV, but in particular the recent outbreak of Covid-19 (caused by SARS-CoV2) have resulted in large numbers of infections worldwide with an estimated several hundred thousand deaths (anticipated fatality rate: <5%). With a comparatively low mortality rate dengue virus causes between 50 and 100 million infections every year, leading to 50,000 deaths. In contrast, Ebola virus is the causative agent for one of the deadliest viral diseases. The Ebola outbreak in West Africa in 2014 is considered the largest outbreak in history with more than 11,000 deaths. Many of the deadliest pathogens such as Ebola virus, influenza virus, mycobacterium tuberculosis, dengue virus, and cholera exploit the endo-lysosomal trafficking system of host cells for penetration into the cytosol and replication. Defects in endo-lysosomal maturation, trafficking, fusion, or pH homeostasis can efficiently reduce the cytotoxicity caused by these pathogens. Most of these functions critically depend on endo-lysosomal membrane proteins such as transporters and ion channels. In particular, cation channels such as the mucolipins (TRPMLs) or the two-pore channels (TPCs) are involved in all of these aspects of endo-lysosomal integrity. In this review we will discuss the correlations between pathogen toxicity and endo-lysosomal cation channel function, and their potential as drug targets for infectious disease therapy.
在由细菌、病毒、寄生虫或真菌等致病微生物引起的传染病中,当今最常见的有疟疾、结核病、流感、艾滋病毒/艾滋病、埃博拉、登革热和耐甲氧西林金黄色葡萄球菌(MRSA)感染,以及最近的新冠病毒病(SARS-CoV2)。其他有着相当毁灭性历史和高死亡率的疾病,如鼠疫、霍乱或斑疹伤寒,如今似乎威胁较小,但尚未根除,而且随着当前抗生素疗效的下降,它们应受到密切关注。在这种情况下,另一个新出现的问题是医疗保健相关感染。在美国,每年约有10万名住院患者(www.cdc.gov),在欧洲约有3.3万名住院患者(https://www.ecdc.europa.eu)因对抗生素耐药的细菌感染而直接死亡。在病毒感染中,流感每年导致约300万至500万例重症病例,约25万至50万人死亡(www.who.int)。目前约有3700万人感染艾滋病毒,每年约有100万人死于该病。中东呼吸综合征冠状病毒(MERS-CoV)、严重急性呼吸综合征冠状病毒(SARS-CoV)等冠状病毒,尤其是最近爆发的新冠病毒病(由SARS-CoV2引起)已在全球导致大量感染,估计有数十万例死亡(预期死亡率:<5%)。登革热病毒死亡率相对较低,但每年导致5000万至1亿例感染,造成5万人死亡。相比之下,埃博拉病毒是最致命的病毒性疾病之一的病原体。2014年西非的埃博拉疫情被认为是历史上最大的疫情,死亡人数超过1.1万。许多最致命的病原体,如埃博拉病毒、流感病毒、结核分枝杆菌、登革热病毒和霍乱,利用宿主细胞的内溶酶体运输系统进入细胞质并进行复制。内溶酶体成熟、运输、融合或pH稳态的缺陷可有效降低这些病原体引起的细胞毒性。这些功能大多严重依赖于内溶酶体膜蛋白,如转运体和离子通道。特别是,阳离子通道,如黏脂素(TRPMLs)或双孔通道(TPCs),参与了内溶酶体完整性的所有这些方面。在这篇综述中,我们将讨论病原体毒性与内溶酶体阳离子通道功能之间的相关性,以及它们作为传染病治疗药物靶点的潜力。